4-Hydroxytamoxifen: Technical Guidance for Cancer Research Workflows

What This Product Solves

4-Hydroxytamoxifen (4-OHT) addresses the need for a reliable, high-purity estrogen receptor modulator in laboratory workflows that focus on breast cancer research, prostate cancer studies, and cardiac myocyte calcium handling assays. By selectively modulating estrogen receptor activity, it enables interrogation of hormone-dependent signaling and antiproliferative mechanisms in preclinical settings. Its DMSO-soluble formulation, with a molecular weight of 387.51 and chemical formula C26H29NO2, ensures suitability for both in vitro and in vivo experimental designs where aqueous or ethanol solubility is not required. The compound's demonstrated effects on cellular contractility and its role in endocrine modulation make it especially relevant for researchers studying the interplay between hormone signaling and disease pathology.

For further details on cancer research protocol implementation, see 4-Hydroxytamoxifen: Protocol Guidance for Cancer Research Workflows, which outlines key considerations for DMSO-based workflows. Additional technical handling recommendations are available in 4-Hydroxytamoxifen: Technical Guidance for Laboratory Use.

Protocol Parameters

• Assay: In vitro apoptosis assay
  Value with unit: 4-Hydroxytamoxifen dissolved at ≥42 mg/mL in DMSO
  Applicability: Suitable for cell-based assays investigating apoptosis or antiproliferative effects in breast or prostate cancer models.
  Rationale: High solubility in DMSO ensures accurate dosing and reproducibility; insolubility in aqueous and ethanol solvents necessitates exclusive use of DMSO for stock solutions.
  Source type: Product dossier / workflow recommendation
• Assay: Cardiac myocyte calcium handling study
  Value with unit: Compound supplied at ~98% purity (HPLC/NMR verified)
  Applicability: Appropriate for mechanistic studies on calcium handling and contractility in isolated cardiac myocytes.
  Rationale: Verified purity is essential for signal specificity and minimizing off-target effects in contractility or calcium flux measurements.
  Source type: Product dossier
• Assay: In vivo modulation of dopaminergic toxicity (mouse studies)
  Value with unit: Solid storage at -20°C; avoid long-term storage of DMSO solutions
  Applicability: For animal studies (e.g., in C57BL/6J mice), maintaining compound stability is critical for reproducible outcomes.
  Rationale: Solid-state storage prevents degradation and preserves compound integrity over time; DMSO solutions are prone to instability with prolonged storage.
  Source type: Product dossier / workflow recommendation

Workflow Setup and QC Checklist

• Reagent Preparation: Dissolve 4-Hydroxytamoxifen exclusively in DMSO to achieve concentrations ≥42 mg/mL. Confirm clarity and absence of precipitate before use.
• Storage: Store the compound as a solid at -20°C in a sealed, desiccated container. Prepare fresh DMSO solutions immediately before use; discard any unused solution after each experimental batch.
• Purity Verification: Check batch documentation for HPLC and NMR purity data (~98%). Avoid using reagent if purity cannot be confirmed.
• Assay Controls: Include vehicle (DMSO-only) controls in all in vitro and in vivo experiments to account for solvent effects.
• Documentation: Record lot numbers, preparation dates, and storage conditions in laboratory logs to enable troubleshooting and audit trails.

Common Failure Modes and Fixes

• Failure Mode: Precipitation or incomplete dissolution in DMSO.
  Fix: Warm the vial gently to room temperature and vortex thoroughly. Do not attempt to dissolve in water or ethanol, as the compound is insoluble in these solvents.
• Failure Mode: Loss of compound potency over time.
  Fix: Adhere strictly to solid-state storage at -20°C. Prepare DMSO solutions fresh for each use and avoid repeated freeze-thaw cycles.
• Failure Mode: Variable assay results.
  Fix: Standardize dosing protocols, use freshly prepared solutions, and implement rigorous control conditions. Ensure that vehicle controls are included in every assay.

Scope and Limitations

4-Hydroxytamoxifen is specifically optimized for laboratory workflows demanding a selective estrogen receptor modulator for cancer research and cardiac myocyte signaling studies. Its use is limited by its solubility profile—only DMSO should be used as a solvent, precluding its application in protocols necessitating aqueous or ethanol dissolution. The product is not intended for clinical or diagnostic use and is not suitable for workflows where solvent compatibility with water or ethanol is required. Application boundaries should be respected to maintain data integrity and reproducibility.

Conclusion

4-Hydroxytamoxifen (SKU B6167) provides a high-purity, DMSO-soluble reagent that supports robust, reproducible research in breast cancer, prostate cancer, and cardiac myocyte calcium handling studies. By adhering to recommended storage, solubility, and preparation practices, laboratories can minimize common sources of assay variability and ensure the integrity of experimental outcomes. For more detailed product specifications and ordering information, refer to 4-Hydroxytamoxifen at APExBIO.